148 related articles for article (PubMed ID: 35651332)
1. Dysfunctional pancreatic cells differentiated from induced pluripotent stem cells with mitochondrial DNA mutations.
So S; Lee S; Lee Y; Han J; Kang S; Choi J; Kim B; Kim D; Yoo HJ; Shim IK; Oh JY; Lee YN; Kim SC; Kang E
BMB Rep; 2022 Sep; 55(9):453-458. PubMed ID: 35651332
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial genome mutations and neuronal dysfunction of induced pluripotent stem cells derived from patients with Alzheimer's disease.
Lee Y; Kim M; Lee M; So S; Kang SS; Choi J; Kim D; Heo H; Lee SS; Park HR; Ko JJ; Song J; Kang E
Cell Prolif; 2022 Jul; 55(7):e13274. PubMed ID: 35698260
[TBL] [Abstract][Full Text] [Related]
3. Selection of iPSCs without mtDNA deletion for autologous cell therapy in a patient with Pearson syndrome.
Lee Y; Han J; Hwang SB; Kang SS; Son HB; Jin C; Kim JE; Lee BH; Kang E
BMB Rep; 2023 Aug; 56(8):463-468. PubMed ID: 37156631
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial genome mutations in mesenchymal stem cells derived from human dental induced pluripotent stem cells.
Park J; Lee Y; Shin J; Lee HJ; Son YB; Park BW; Kim D; Rho GJ; Kang E
BMB Rep; 2019 Dec; 52(12):689-694. PubMed ID: 31234953
[TBL] [Abstract][Full Text] [Related]
5. Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs.
Yang Y; Wu H; Kang X; Liang Y; Lan T; Li T; Tan T; Peng J; Zhang Q; An G; Liu Y; Yu Q; Ma Z; Lian Y; Soh BS; Chen Q; Liu P; Chen Y; Sun X; Li R; Zhen X; Liu P; Yu Y; Li X; Fan Y
Protein Cell; 2018 Mar; 9(3):283-297. PubMed ID: 29318513
[TBL] [Abstract][Full Text] [Related]
6. Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.
Folmes CD; Martinez-Fernandez A; Perales-Clemente E; Li X; McDonald A; Oglesbee D; Hrstka SC; Perez-Terzic C; Terzic A; Nelson TJ
Stem Cells; 2013 Jul; 31(7):1298-308. PubMed ID: 23553816
[TBL] [Abstract][Full Text] [Related]
7. mRNA Reprogramming of T8993G Leigh's Syndrome Fibroblast Cells to Create Induced Pluripotent Stem Cell Models for Mitochondrial Disorders.
Grace HE; Galdun P; Lesnefsky EJ; West FD; Iyer S
Stem Cells Dev; 2019 Jul; 28(13):846-859. PubMed ID: 31017045
[TBL] [Abstract][Full Text] [Related]
8. Human induced pluripotent stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell-like metabolic reprogramming.
Prigione A; Lichtner B; Kuhl H; Struys EA; Wamelink M; Lehrach H; Ralser M; Timmermann B; Adjaye J
Stem Cells; 2011 Sep; 29(9):1338-48. PubMed ID: 21732474
[TBL] [Abstract][Full Text] [Related]
9. The relevance of mitochondrial DNA variants fluctuation during reprogramming and neuronal differentiation of human iPSCs.
Palombo F; Peron C; Caporali L; Iannielli A; Maresca A; Di Meo I; Fiorini C; Segnali A; Sciacca FL; Rizzo A; Levi S; Suomalainen A; Prigione A; Broccoli V; Carelli V; Tiranti V
Stem Cell Reports; 2021 Aug; 16(8):1953-1967. PubMed ID: 34329598
[TBL] [Abstract][Full Text] [Related]
10. Cell reprogramming shapes the mitochondrial DNA landscape.
Wei W; Gaffney DJ; Chinnery PF
Nat Commun; 2021 Sep; 12(1):5241. PubMed ID: 34475388
[TBL] [Abstract][Full Text] [Related]
11. Generation of iPSC-derived insulin-producing cells from patients with type 1 and type 2 diabetes compared with healthy control.
Kim MJ; Lee EY; You YH; Yang HK; Yoon KH; Kim JW
Stem Cell Res; 2020 Oct; 48():101958. PubMed ID: 32882526
[TBL] [Abstract][Full Text] [Related]
12. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
13. TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation.
Yahata N; Matsumoto Y; Omi M; Yamamoto N; Hata R
Sci Rep; 2017 Nov; 7(1):15557. PubMed ID: 29138463
[TBL] [Abstract][Full Text] [Related]
14. Age-Related Accumulation of Somatic Mitochondrial DNA Mutations in Adult-Derived Human iPSCs.
Kang E; Wang X; Tippner-Hedges R; Ma H; Folmes CD; Gutierrez NM; Lee Y; Van Dyken C; Ahmed R; Li Y; Koski A; Hayama T; Luo S; Harding CO; Amato P; Jensen J; Battaglia D; Lee D; Wu D; Terzic A; Wolf DP; Huang T; Mitalipov S
Cell Stem Cell; 2016 May; 18(5):625-36. PubMed ID: 27151456
[TBL] [Abstract][Full Text] [Related]
15. Concise Review: Heteroplasmic Mitochondrial DNA Mutations and Mitochondrial Diseases: Toward iPSC-Based Disease Modeling, Drug Discovery, and Regenerative Therapeutics.
Hatakeyama H; Goto Y
Stem Cells; 2016 Apr; 34(4):801-8. PubMed ID: 26850516
[TBL] [Abstract][Full Text] [Related]
16. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathomechanisms and cell-type-specific disease phenotypes of MELAS caused by mutant mitochondrial tRNA(Trp).
Hatakeyama H; Katayama A; Komaki H; Nishino I; Goto Y
Acta Neuropathol Commun; 2015 Aug; 3():52. PubMed ID: 26297375
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial disease: mtDNA and protein segregation mysteries in iPSCs.
Pickrell AM; Youle RJ
Curr Biol; 2013 Dec; 23(23):R1052-4. PubMed ID: 24309284
[TBL] [Abstract][Full Text] [Related]
19. Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders.
Lorenz C; Lesimple P; Bukowiecki R; Zink A; Inak G; Mlody B; Singh M; Semtner M; Mah N; Auré K; Leong M; Zabiegalov O; Lyras EM; Pfiffer V; Fauler B; Eichhorst J; Wiesner B; Huebner N; Priller J; Mielke T; Meierhofer D; Izsvák Z; Meier JC; Bouillaud F; Adjaye J; Schuelke M; Wanker EE; Lombès A; Prigione A
Cell Stem Cell; 2017 May; 20(5):659-674.e9. PubMed ID: 28132834
[TBL] [Abstract][Full Text] [Related]
20. Generation of β Cells from iPSC of a MODY8 Patient with a Novel Mutation in the Carboxyl Ester Lipase (CEL) Gene.
Pellegrini S; Pipitone GB; Cospito A; Manenti F; Poggi G; Lombardo MT; Nano R; Martino G; Ferrari M; Carrera P; Sordi V; Piemonti L
J Clin Endocrinol Metab; 2021 Apr; 106(5):e2322-e2333. PubMed ID: 33417713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
